3 条结果 关键词:KinExA ×

Novel ultrasensitive automated kinetic exclusion assay for measurement of plasma levels of soluble PD-L1, the predictive and prognostic biomarker in cancer patients treated with immune checkpoint inhibitors.

Heliyon 2024 Darwish IA, Alahmad W, Vinoth R

血浆或血清中可溶性程序性死亡配体1(PD-L1)水平被提出作为免疫检查点抑制剂治疗癌症患者的预测和预后生物标志物,但现有方法灵敏度、重现性和准确性有限。本研究开发超灵敏自动化流动式动力学排除分析(KinExA),用于血浆可溶性PD-L1的准确测量。基于KinExA™ 3200生物传感器,样品中PD-L1先与抗PD-L1单克隆抗体预平...

Automated flow fluorescent noncompetitive immunoassay for measurement of human plasma levels of monoclonal antibodies used for immunotherapy of cancers with KinExA™ 3200 biosensor.

Talanta 2019 AlRabiah H, Hamidaddin MA, Darwish IA

本研究首次开发基于动力学排阻分析(KinExA)的自动流动荧光非竞争免疫分析方法,用于定量测定人血浆中用于癌症免疫治疗的单克隆抗体(mAbs)水平。该方法在 KinExA 3200 生物传感器上建立,并以贝伐珠单抗(BEV)和西妥昔单抗(CET)为代表进行优化与验证,分别采用其特异性抗原人血管内皮生长因子(VEGF)和表皮生长因子受...

Exploring the dynamic range of the kinetic exclusion assay in characterizing antigen-antibody interactions.

PloS one 2012 Bee C, Abdiche YN, Stone DM, Collier S 等 8 人

治疗性抗体通常被工程化或筛选为具有极高的靶点结合亲和力,而多数生物物理方法难以精确测定。本文以抗 Dickkopf(DKK)单克隆抗体 DS4 与一组 DKK 抗原的相互作用为模型,探索动力学排除法(KinExA)的动态范围。通过针对每种抗原定制 KinExA 条件,作者获得了跨越六个数量级的表观平衡解离常数(KD),约从 100 ...